High-frequency use drives disorder risk in midlife cannabis users

This comprehensive study of over 5,400 US adults aged 40-60 examined the relationship between cannabis use patterns and cannabis use disorder (CUD) among midlife users. The research found that nearly 1 in 4 cannabis users report some CUD symptoms, with the prevalence jumping dramatically to nearly half (49.7%) among near-daily users. Importantly, the study distinguished between medical and nonmedical use, revealing that medical cannabis users showed higher rates of CUD symptoms (33.8%) compared to nonmedical users (22.5%), though this difference became less significant when accounting for frequency of use.

The key insight from this longitudinal analysis is that high-frequency cannabis use—regardless of whether it's for medical or nonmedical purposes—is the primary driver of CUD risk. When researchers controlled for how often people used cannabis, the association between medical use and CUD largely disappeared. However, important subgroup differences emerged: among female cannabis users, medical use remained linked to tolerance development even after accounting for frequency, and older adults (ages 55-60) showed persistent CUD risks associated with medical use, including tolerance and moderate-to-severe symptoms.

These findings have significant implications for midlife cannabis users, particularly those using cannabis medically. While frequent use itself is the strongest predictor of developing problematic cannabis use patterns, women and adults over 55 may face elevated risks even with controlled use frequency. The research suggests that users—especially in these demographic groups—should monitor their cannabis use patterns closely and consider whether regular use, particularly daily or near-daily consumption, is compatible with their health goals.